Diffusion and perfusion-weighted magnetic resonance imaging techniques in stroke recovery

Europa Medicophysica

Volumn 43, Issue 2, 2007, Pages 271-284

  Aronen, H J ^a,b,c   Laakso, M P ^d   Moser, M ^c   Perkio J ^c,e  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b Centre of Military Medicine   (Finland)

^c Helsinki Brain Research Center   (Finland)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Magnetic resonance imaging; Rehabilitation; Stroke

Indexed keywords

BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONVALESCENCE; DIFFUSION WEIGHTED IMAGING; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; RECOVERY OF FUNCTION;

EID: 34447571941     PISSN: 00142573     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (108)

1. Schellinger PD, Kaste M, Hacke W. An update on thrombolytic therapy for acute stroke. Curr Opin Neurol 2004;17:69-77.
2. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-7.
3. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245-51.
4. Stejskal EO, Tanner JE. Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient. J Chem Phys 1965;42:288-92.
5. Belliveau JW, Kennedy DN Jr, McKinstry RC, Buchbinder BR, Weisskoff RM, Cohen MS et al. Functional mapping of the human visual cortex by magnetic resonance imaging. Science 1991;254: 716-9.
6. Belliveau JW, Rosen BR, Kantor HL, Rzedzian RR, Kennedy DN, McKinstry RC et al. Functional cerebral imaging by susceptibilitycontrast NMR. Magn Reson Med 1990;14:538-46.
7. Rosen BR, Belliveau JW, Aronen HJ, Kennedy D, Buchbinder BR, Fischman A et al. Susceptibility contrast imaging of cerebral blood volume: human experience. Magn Reson Med 1991;22:293-9.
8. Rosen BR, Belliveau JW, Buchbinder BR, McKinstry RC, Porkka LM, Kennedy DN et al. Contrast agents and cerebral hemodynamics. Magn Reson Med 1991;19:285-92.
9. Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990;14:249-65.
10. Fisel CR, Ackerman JL, Buxton RB, Garrido L, Belliveau JW, Rosen BR et al. MR contrast due to microscopically heterogeneous magnetic susceptibility: numerical simulations and applications to cerebral physiology. Magn Reson Med 1991;17:336-47.
11. Weisskoff RM, Zuo CS, Boxerman JL, Rosen BR. Microscopic susceptibility variation and transverse relaxation: theory and experiment. Magn Reson Med 1994;31:601-10.
12. Boxerman JL, Hamberg LM, Rosen BR, Weisskoff RM. MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med 1995;1995:555-66.
13. Lev MH, Kulke SF, Sorensen AG, Boxerman JL, Brady TJ, Rosen BR et al. Contrast-to-noise ratio in functional MRI of relative cerebral blood volume with sprodiamide injection. J Magn Reson Imaging 1997;7:523-7.
14. Villringer A, Rosen BR, Belliveau JW, Ackerman JL, Lauffer RB, Buxton RB et al. Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn Reson Med 1988;6:164-74.
15. Boxerman JL, Rosen BR, Weisskoff RM. Signal-to-noise analysis of cerebral blood volume maps from dynamic NMR imaging studies. J Magn Reson Imaging 1997;7:528-37.
16. Rosen BR, Belliveau JW, Chien D. Perfusion imaging by nuclear magnetic resonance. Magn Reson Q 1989;5;263-81.
17. Aronen HJ, Gazit IE, Louis DN, Buchbinder BR, Pardo FS, Weisskoff RM et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994; 191:41-51.
18. Aronen HJ, Pardo FS, Kennedy DN, Belliveau JW, Packard SD, Hsu DW et al. High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas. Clin Cancer Res 2000;6:2189-200.
19. Meier P, Zierler KL. On the theory of the indicator-dilution method for measurement of blood flow and volume. J Appl Physiol 1954;6:731-44.
20. Zierler KL. Equations for measuring blood flow by external monitoring of radioisotopes. Circ Res 1965;16:309-21.
21. Perkiö J, Aronen HJ, Kangasmäki A, Liu Y, Karonen J, Savolainen S et al. Evaluation of four post processing methods for determination of cerebral blood volume and mean transit time by dynamic susceptibility contrast imaging. Magn Reson Med 2002;47:973-81.
22. Østergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: mathematical approach and statistical analysis. Magn Reson Med 1996;36:715-25.
23. Østergaard L, Sorensen AG, Kwong KK, Weisskoff RM, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: experimental comparison and preliminary results. Magn Reson Med 1996;36: 726-36.
24. Kuschinsky W, Paulson OB. Capillary circulation in the brain. Cerebrovasc Brain Metab Rev 1992;4:261-86.
25. Gjedde A, Høst Poulsen P, Østergaard L. On the oxygenation of hemoglobin in the human brain. Adv Exp Med Biol 1999;471:67-81.
26. Hudetz AG, Feher G, Kampine JP. Heterogeneous autoregulation of cerebrocortical capillary flow: evidence for functional thoroughfare channels? Microvasc Res 1996;51:131-6.
27. Østergaard L, Sorensen AG, Chesler DA, Weisskoff RM, Koroshetz WJ, Wu O et al. Combined diffusion-weighted and perfusionweighted flow heterogeneity magnetic resonance imaging in acute stroke. Stroke 2000;31:1097-103.
28. Østergaard L, Chesler DA, Weisskoff RM, Sorensen AG, Rosen BR. Modeling cerebral blood flow and flow heterogeneity from magnetic resonance residue data. J Cereb Blood Flow Metab 1999;19:690-9.
29. King RB, Raymond GM, Bassingthwaighte JB. Modeling blood flow heterogeneity. Ann Biomed Eng 1996;24:352-72.
30. Perkiö J, Soinne L, Østergaard L, Helenius J, Kangasmaki A, Martinkauppi S et al. Abnormal intravoxel cerebral blood flow heterogeneity in human ischemic stroke determined by dynamic susceptibility contrast magnetic resonance imaging. Stroke 2005;36:44-9.
31. Weisskoff RM, Chesler D, Boxerman JL, Rosen BR. Pitfalls in MR measurement of tissue blood flow with intravascular tracers: which mean transit time? Magn Reson Med 1993;29:553-8.
32. Stewart GN. Researches on the circulation time in organs and on the influences which affect it. Parts I-III. J Physiol (London) 1894;15:1-89.
33. Ahlhelm F, Schneider G, Backens M, Reith W, Hagen T. Time course of the apparent diffusion coefficient after cerebral infarction. Eur Radiol 2002;12:2322-9.
34. Warach S, Chien D, Li W, Ronthal M, Edelman RR. Fast magnetic resonance diffusion-weighted imaging of acute human stroke. Neurology 1992;42:1717-23.
35. Warach S, Gaa J, Siewert B, Wielopolski P, Edelman RR. Acute human stroke studied by whole brain echo planar diffusionweighted magnetic resonance imaging. Ann Neurol 1995;37:231-41.
36. Schwamm LH, Koroshetz WJ, Sorensen AG, Wang B, Copen WA, Budzik R et al. Time course of lesion development in patients with acute stroke: serial diffusion- and hemodynamic-weighted magnetic resonance imaging. Stroke 1998;29:2268-76.
37. Oliveira-Filho J, Ay H, Schaefer PW, Buonanno FS, Chang Y, Gonzalez RG et al. Diffusion-weighted magnetic resonance imaging identifies the "clinically relevant" small-penetrator infarcts. Arch Neurol 2000;57:1009-14.
38. Karonen JO, Vanninen RL, Liu Y, Østergaard L, Kuikka JT, Nuutinen J et al. Combined diffusion and perfusion MRI with correlation to single-photon emission CT in acute ischemic stroke: ischemic penumbra predicts infarct growth. Stroke 1999;30:1583-90.
39. Sorensen AG, Buonanno FS, Gonzalez RG, Schwamm LH, Lev MH, Huang-Hellinger FR et al. Hyperacute stroke: evaluation with combined multisection diffusion-weighted and hemodynamically weighted echo-planar MR imaging. Radiology 1996;199:391-401.
40. Karonen JO, Liu Y, Vanninen RL, Østergaard L, Partanen PLK, Vainio PA et al. Combined perfusion- and diffusion-weighted MR imaging in acute ischemic stroke during the 1st week: a longitudinal study. Radiology 2000;217:886-94.
41. Mezzapesa DM, Petruzzellis M, Lucivero V, Prontera M, Tinelli A, Sancilio M et al. Multimodal MR examination in acute ischemic stroke. Neuroradiology 2006;48:238-46.
42. Fiehler J, von Bezold M, Kucinski T, Knab R, Eckert B, Wittkugel O, et al. Cerebral blood flow predicts lesion growth in acute stroke patients. Stroke 2002;33:2421-5.
43. Li F, Han SS, Tatlisumak T, Liu KF, Garcia JH, Sotak CH et al. Reversal of acute apparent diffusion coefficient abnormalities and delayed neuronal death following transient focal cerebral ischemia in rats. Ann Neurol 1999;46:333-42.
44. Karonen JO, Nuutinen J, Kuikka JT, Vanninen EJ, Vanninen RL, Partanen PL et al. Combined SPECT and diffusion-weighted MRI as a predictor of infarct growth in acute ischemic stroke. J Nucl Med 2000;41:788-94.
45. Liu Y, Karonen JO, Vanninen RL, Nuutinen J, Koskela A, Soimakallio S et al. Acute ischemic stroke: predictive value of 2D phase-contrast MR angiography-serial study with combined diffusion and perfusion MR imaging. Radiology 2004;231:517-27.
46. Kucinski T, Naumann D, Knab R, Schoder V, Wegener S, Fiehler J et al. Tissue at risk is overestimated in perfusion-weighted imaging: MR imaging in acute stroke patients without vessel recanalization. AJNR Am J Neuroradiol 2005;26:815-9.
47. Liu Y, Karonen JO, Vanninen RL, Nuutinen J, Perkiö J, Vainio PA et al. Detecting the subregion proceeding to infarction in hypoperfused cerebral tissue: a study with diffusion and perfusion weighted MRI. Neuroradiology 2003;45:345-51.
48. Wu O, Koroshetz WJ, Østergaard L, Buonanno FS, Copen WA, Gonzalez RG et al. Predicting tissue outcome in acute human cerebral ischemia using combined diffusion- and perfusion-weighted MR imaging. Stroke 2001;32:933-42.
49. Liu Y, Karonen JO, Vanninen RL, Østergaard L, Roivainen R, NuutinenJ et al. Cerebral hemodynamics in human acute ischemic stroke: a study with diffusion- and perfusion-weighted magnetic resonance imaging and SPECT. J Cereb Blood Flow Metab 2000;20:910-20.
50. Butcher K, Parsons M, Baird T, Barber A, Donnan G, Desmond P et al. Perfusion thresholds in acute stroke thrombolysis. Stroke 2003;34:2159-64.
51. Rivers CS, Wardlaw JM, Armitage PA, Bastin ME, Carpenter TK, Cvoro V et al. Persistent infarct hyperintensity on diffusion-weighted imaging late after stroke indicates heterogeneous, delayed, infarct evolution. Stroke 2006;37:1418-23.
52. Nuutinen J, Liu Y, Laakso MP, Karonen JO, Roivainen R, Vanninen RL et al. Assessing the outcome of stroke: a comparison between MRI and clinical stroke scales. Acta Neural Scand 2006;113:100-7.
53. Bang OY, Lee PH, Heo KG, Joo US, Yoon SR, Kim SY. Specific DWI lesion patterns predict prognosis after acute ischaemic stroke within the MCA territory. J Neurol Neurosurg Psychiatry 2005;76: 1222-8.
54. Barber PA, Darby DG, Desmond PM, Yang Q, Gerraty RP, Jolley D et al. Prediction of stroke outcome with echo planar perfusionand diffusion-weighted MRI. Neurology 1998;1998:418-26.
55. Rordorf G, Koroshetz WJ, Copen WA, Cramer SC, Schaefer PW, Budzik RF Jr et al. Regional ischemia and ischemic injury in patients with acute middle cerebral artery stroke as defined by early diffusion-weighted and perfusion-weighted MRI. Stroke 1998;29:939-43.
56. Sorensen AG, Copen WA, Østergaard L, Buonanno FS, Gonzalez RG, Rordorf G et al. Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow and mean transit time. Radiology 1999;210:519-27.
57. Parsons MW, Yang Q, Barber PA, Darby DG, Desmond PM, Gerraty RP et al. Perfusion magnetic resonance imaging maps in hyperacute stroke. Relative cerebral blood flow most accurately identifies tissue destined to infarct. Stroke 2001;32:1581-7.
58. Aronen HJ, Perkiö J, Karonen JO, Vanninen RL, Østergaard L, Liu Y, et al. Perfusion weighted MRI in human acute ischemic stroke: a comparison with the progression of the infarct on diffusion-weighted images. Acad Radiol 2002;9 Suppl 1:S160-4.
59. Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006;60:508-17.
60. Kane I, Sandercock P, Wardlaw J. Magnetic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke: a systematic review of the evidence to date. J Neurol Neurosurg Psychiatry 2007;78:485-91.
61. Karonen JO, Partanen PL, Vanninen RL, Vainio PA, Aronen HJ. Evolution of MR contrast enhancement patterns during the first week after acute ischemic stroke. AJNR Am J Neuroradiol 2001;22:103-11.
62. Liu Y, Laakso MP, Karonen JO, Vanninen RL, Nuutinen J, Soimakallio S et al. Apolipoprotein E polymorphism and acute ischemic stroke: a diffusion- and perfusion-weighted magnetic resonance imaging study. J Cereb Blood Flow Metab 2002;22:1336-42.
63. Liu Y, Nuutinen J, Laakso MP, Karonen JO, Soimakallio S, Aronen HJ et al. ApoE polymorphism and acute stroke: a study with diffusion- and perfusion-weighted MRI and MR angiography. Acta Neurol Scand 2006;114:323-8.
64. Kidwell CS, Alger JR, Saver JL. Evolving paradigms in neuroimaging of the ischemic penumbra. Stroke 2004;35:2662-5.
65. Butcher KS, Parsons M, MacGregor L, Barber PA, Chalk J, Bladin C et al. Refining the perfusion-diffusion mismatch hypothesis. Stroke 2005;36:1153-9.
66. Kidwell CS, Saver JL, Mattiello J, Starkman S, Vinuela F, Duckwiler G et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol 2000;47:462-9.
67. Prasser J, Butcher K, Allport L, Parsons M, MacGregor L, Desmond P et al. Clinical-diffusion mismatch predicts the putative penumbra with high specificity. Stroke 2005;36:1700-4.
68. Davalos A, Blanco M, Pedraza S, Leira R, Castellanos M, Pumar JM et al. The clinical-DWI mismatch: a new diagnostic approach to the brain tissue at risk of infarction. Neurology 2004;62:2187-92.
69. Lansberg MG, Thijs VN, Bammer R, Wechsler LR, O'Donnell MJ, Olshen RA et al. Who is most likely to benefit from tPA? The perfusion-diffusion and clinical-diffusion mismatch models disagree. Stroke 2005;36:437.
70. Helenius J, Perkiö J, Soinne L, Østergaard L, Carano RA, Salonen O et al. Cerebral hemodynamics in a healthy population measured by dynamic susceptibility contrast MR imaging. Acta Radiol 2003;44:538-46.
71. Simon JE, Bristow MS, Lu H, Lauzon ML, Brown RA, Manjon JV et al. A novel method to derive separate gray and white matter cerebral blood flow measures from MR imaging of acute ischemic stroke patients. J Cereb Blood Flow Metab 2005;25: 1236-43.
72. Arakawa S, Wright PM, Koga M, Phan TG, Reutens DC, Lim I et al. Ischemic thresholds for gray and white matter: a diffusion and perfusion magnetic resonance study. Stroke 2006;37:1211-6.
73. Falcao AL, Reutens DC, Markus R, Koga M, Read SJ, Tochon-Danguy H et al. The resistance to ischemia of white and gray matter after stroke. Ann Neurol 2004;56:695-701.
74. Koga M, Reutens DC, Wright P, Phan T, Markus R, Pedreira B et al. The existence and evolution of diffusion-perfusion mismatched tissue in white and gray matter after acute stroke. Stroke 2005;36:2132-7.
75. Counsell C, Dennis M, McDowall M, Warlow C. Predicting outcome after acute and subacute stroke: development and validation of new prognostic models. Stroke 2002;33:1041-7.
76. Johnston KC, Connors AF Jr, Wagner DP, Haley EC, Jr. Predicting outcome in ischemic stroke: external validation of predictive risk models. Stroke 2003;34:200-2.
77. Jacobs MA, Zhang ZG, Knight RA, Soltanian-Zadeh H, Goussev AV, Peck DJ et al. A model for multiparametric MRI tissue characterization in experimental cerebral ischemia with histological validation in rat: part 1. Stroke 2001;32:943-9.
78. Mitsias PD, Jacobs MA, Hammoud R, Pasnoor M, Santhakumar S, Papamitsakis NI et al. Multiparametric MRI ISODATA ischemic lesion analysis: correlation with the clinical neurological deficit and single-parameter MRI techniques. Stroke 2002;33:2839-44.
79. Lu M, Mitsias PD, Ewing JR, Soltanian-Zadeh H, Bagher-Ebadian H, Zhao Q et al. Predicting final infarct size using acute and subacute multiparametric MRI measurements in patients with ischemic stroke. J Magn Reson Imaging 2005;21:495-502.
80. Menezes NM, Ay H, Wang Zhu M, Lopez CJ, Singhal AB, Karonen JO, et al. The real estate factor: quantifying the impact of infarct location on stroke severity. Stroke 2007;38:194-7.
81. Wu O, Sumii T, Asahi M, Sasamata M, Østergaard L, Rosen BR et al. Infarct prediction and treatment assessment with MRI-based algorithms in experimental stroke models. J Cereb Blood Flow Metab 2007;27:196-204.
82. Lorenz C, Benner T, Chen PJ, Lopez CJ, Ay H, Zhu MW et al. Automated perfusion-weighted MRI using localized arterial input functions. J Magn Reson Imaging 2006;24:1133-9.
83. Mouridsen K, Friston K, Hjort N, Gyldensted L, Østergaard L, Kiebel S. Bayesian estimation of cerebral perfusion using a physiological model of microvasculature. Neuroimage 2006;33:570-9.
84. Rose SE, Chalk JB, Griffin MP, Janke AL, Chen F, McLachan GJ et al. MRI based diffusion and perfusion predictive model to estimate stroke evolution. Magn Reson Imaging 2001;19:1043-53.
85. Baird AE, Dambrosia J, Janket S, Eichbaum Q, Chaves C, Silver B et al. A three-item scale for the early prediction of stroke recovery. Lancet 2001;357:2095-9.
86. Gottrup C, Thomsen K, Locht P, Wu O, Sorensen AG, Koroshetz WJ et al. Applying instance-based techniques to prediction of final outcome in acute stroke. Artif Intell Med 2005;33:223-36.
87. Rother J, Schellinger PD, Gass A, Siebler M, Villringer A, Fiebach JB et al. Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6 hours. Stroke 2002;33: 2438-45.
88. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP et al. Association of outcome with early stroke treatment: pooled analysis of ATLAKTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004;363:768-74.
89. Chalela JA, Kang DW, Luby M, Ezzeddine M, Latour LL, Todd JW et al. Early magnetic resonance imaging findings in patients receiving tissue plasminogen activator predict outcome: insights into the pathophysiology of acute stroke in the thrombolysis era. Ann Neurol 2004;55:105-12.
90. Nighoghossian N, Hermier M, Adeleine P, Derex L, Dugor JF, Philippeau F et al. Baseline magnetic resonance imaging parameters and stroke outcome in patients treated by intravenous tissue plasminogen activator. Stroke 2003;34:458-63.
91. Pan J, Konstas AA, Bateman B, Ortolano GA, Pile-Spellman J. Reperfusion injury following cerebral ischemia: pathophysiology, MR imaging, and potential therapies. Neuroradiology 2007;49: 93-102.
92. Lee DH, Jo KD, Kim HG, Choi SJ, Jung SM, Ryu DS et al. Local intraarterial urokinase thrombolysis of acute ischemic stroke with or without intravenous abciximab: a pilot study. J Vase Interv Radiol 2002;13:769-74.
93. Sugg RM, Pary JK, Uchino K, Baraniuk S, Shaltoni HM, Gonzales NR et al. Argatroban tPA stroke study: study design and results in the first treated cohort. Arch Neurol 2006;63:1057-62.
94. Sacco RL, Chong JY, Prabhakaran S, Elkind MS. Experimental treatments for acute ischaemic stroke. Lancet 2007;369:331-41.
95. Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:66-73.
96. Daffertshofer M, Hennerici MG. Sonothrombolysis: experimental evidence. Front Neurol Neurosci 2006;21:140-9.
97. Leonardi-Bee J, Bath PM, Phillips SJ, Sandercock PA. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002;33:1315-20.
98. Masdeu JC, Irimia P, Asenbaum S, Bogousslavsky J, Brainin M, Chabriat H et al. EFNS guideline on neuroimaging in acute stroke. Report of an EFNS task force. Eur J Neurol. 2006;13:1271-83.
99. Gonzalez RG, Schaefer PW, Buonanno FS, Schwamm LH, Budzik RF, Rordorf G et al. Diffusion-weighted MR imaging: diagnostic accuracy in patients imaged within 6 hours of stroke symptom onset. Radiology 1999;210:155-62.
100. Chalela JA, Kidwell CS, Nentwich LM, Luby M, Butman JA, Demchuk AM et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet 2007;369:293-8.
101. Lutsep H, Albers G, De Crespigny A, Kamat GN, Marks MP, Moseley M. Clinical utility of diffusion-weighted magnetic resonance imaging in the assessment of ischemic stroke. Ann Neurol 1997;41:574-80.
102. Fiebach JB, Schellinger PD, Gass A, Kucinski T, Siebler M, Villringer A et al. Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke 2004;35:502-6.
103. Kidwell CS, Chalela JA, Saver JL, Starkman S, Hill MD, Demchuk AM et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA 2004;292:1823-30.
104. Schellinger PD. Safe implementation of thrombolysis in stroke trial. International Stroke Conference, 2007, February 7-9, San Francisco, CA.
105. Guadagno JV, Warburton EA, Aigbirhio FI, Smielewski P, Fryer TD, Harding S et al. Does the acute diffusion-weighted imaging lesion represent penumbra as well as core? A combined quantitative PET/MRI voxel-based study. J Cereb Blood Flow Metab 2004;24:1249-54.
106. Guadagno JV, Warburton EA, Jones PS, Day DJ, Aigbirhio FI, Fryer TD et al. How affected is oxygen metabolism in DWI lesions? A combined acute stroke PET-MR study. Neurology 2006;67:824-9.
107. Wikström H, Roine RO, Aronen HJ, Salonen O, Sinkkonen J, Ilmoniemi RJ et al. Specific changes in somatosensory evoked magnetic fields during recovery from sensorimotor stroke. Ann Neurol 2000;47:353-60.
108. Surikova I, Meisel S, Siebler M, Wittsack HJ. Significance of the perfusion-diffusion mismatch in chronic cerebral ischemia. J Magn Reson Imaging 2006;24:771-8.